Dachaigh › Leukemia Lymphocytic Cronach › Florida › Jacksonville
Sgrùdaidhean clionaigeach Leukemia Lymphocytic Cronach ann an Jacksonville, FL
Tha aon sgrùdadh airson Leukemia Lymphocytic Cronach a’ lorg phàirtichean aig làrach ann no faisg air Jacksonville. Fosglaidh e gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
A’ fastadhÌre 1/2
- Mayo Clinic Jacksonville, Jacksonville
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
A’ fastadhÌre 3
- Baptist Md Anderson Cancer Center, Jacksonville
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
A’ fastadhÌre 3
- Mayo Clinic Jacksonville, Jacksonville
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A’ fastadhÌre 3
- Mayo Clinic Jacksonville, Jacksonville
- Cancer Specialists of North Florida, Jacksonville
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
A’ fastadhÌre 4
- Cancer Specialists, LLC, Jacksonville
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
A’ fastadhÌre 3
- Mayo Clinic - Jacksonville, Jacksonville
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
A’ fastadhÌre 1/2
- Mayo Clinic, Jacksonville
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
A’ fastadhÌre 1/2
- Mayo Clinic, Clinical Trials Referral Office, Jacksonville
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
A’ fastadhÌre 3
- Cancer Specialists of North Florida - Jacksonville - AC Skinner Parkway /ID# 266713, Jacksonville
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
A’ fastadhÌre 4
- Cancer Specialists, LLC, Jacksonville
B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies
A’ fastadhÌre 1
- Mayo Clinic in Florida, Jacksonville
Sgrùdaidhean Leukemia Lymphocytic Cronach ann am bailtean eile
- Boston, MA31 sgrùdaidhean
- Columbus, OH28 sgrùdaidhean
- Durham, NC27 sgrùdaidhean
- Washington, DC22 sgrùdaidhean
- Seattle, WA20 sgrùdaidhean
- Rochester, MN18 sgrùdaidhean
- New York City, NY18 sgrùdaidhean
- Houston, TX17 sgrùdaidhean
- Baldwin Park, CA16 sgrùdaidhean
- Milwaukee, WI15 sgrùdaidhean
- Chicago, IL14 sgrùdaidhean
- Cincinnati, OH14 sgrùdaidhean
Sgrùdaidhean eile ann an Jacksonville
- Aillse a' bhroilleach40 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag39 sgrùdaidhean
- Aillse (gach seòrsa)29 sgrùdaidhean
- Ailse metastatach28 sgrùdaidhean
- Aillse colorectal27 sgrùdaidhean
- Aillse Prostata26 sgrùdaidhean
- Obesity25 sgrùdaidhean
- Fàilligeadh a' Chridhe21 sgrùdaidhean
- Cancer Pancreatic20 sgrùdaidhean
- Ro-throm19 sgrùdaidhean
- Myeloma iomaill18 sgrùdaidhean
- Ailseachadh nan Sgamhan17 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.